Search Results 121-130 of 26258 for ulcerative colitis

  1. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis - Mayo Clinic

    Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis · Overview · Participation eligibility.

  2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...

  3. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis.

  4. Diarrhea - Mayo Clinic

    Ulcerative colitis · Ulcerative colitis flare-ups: 5 tips to manage them · Vesicoureteral reflux · How irritable bowel syndrome affects you · Vitamin deficiency ...

  5. Budesonide (Oral Route) Proper Use - Mayo Clinic

    Children—Use and dose must be determined by your doctor. For oral dosage form (extended-release tablets):. For mild to moderate ulcerative colitis: Adults—9 ...

  6. Francis A. Farraye, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    ... Ulcerative Colitis and Questions and Answers about Crohn's Disease. His newest book, published in 2022 is Mayo Clinic on Crohn's Disease and Ulcerative Colitis.

  7. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

  8. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    Ozanimod will be administered orally to pediatric participants with moderate to severe active Ulcerative Colitis who have had an inadequate response to ...

  9. A Study to Evaluate the Accuracy of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  10. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...